Alkermes plc diskutieren
Alkermes plc
WKN: A1JKVH / Symbol: ALKS / Name: Alkermes / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
?
0,00 %
Alkermes plc (NASDAQ: ALKS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $48.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $48.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $37.00 price target on the stock, down previously from $38.00.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target lowered by analysts at Cantor Fitzgerald from $48.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $32.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $36.00 price target on the stock, up previously from $25.00.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Mizuho from $35.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $40.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $30.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $40.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its price target raised by analysts at Robert W. Baird from $38.00 to $41.00. They now have an "outperform" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $45.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $42.00 price target on the stock, up previously from $33.00.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $43.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes plc (NASDAQ: ALKS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) was upgraded by analysts at Royal Bank Of Canada from a "sector perform" rating to an "outperform" rating. They now have a $44.00 price target on the stock, up previously from $42.00.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Mizuho from $40.00 to $45.00. They now have an "outperform" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) was given a new $56.00 price target on by analysts at Jefferies Financial Group Inc.. They now have a "buy" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Alkermes (NASDAQ:ALKS) had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $42.00. They now have an "overweight" rating on the stock.
Ratings data for ALKS provided by MarketBeat
Neueste Beiträge
BTIG_Research in Kirby Corp. diskutieren